Tag: pharmaceutical company in usa

August 16, 2018

Evoke Pharma’s Gimoti NDA Accepted for FDA Review

Evoke Pharma (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the Company’s 505(b)(2)...
August 15, 2018

Acura Pharmaceuticals Announces Second Quarter 2018 Financial Results

Acura Pharmaceuticals (OTCQB:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the three and six months...
August 10, 2018

Iterum Initiates SURE 1, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections

Iterum Therapeutics (Nasdaq:ITRM), a clinical-stage pharmaceutical company developing antibiotics against multi-drug resistant pathogens, today announced its initiation of the first...
August 10, 2018

Corcept Therapeutics Announces Second Quarter 2018 Financial Results and Stock Repurchase Program; Provides Clinical Update

Corcept Therapeutics (NASDAQ:CORT), a company engaged in the discovery, development and commercialization of drugs to treat severe metabolic, oncologic and...
August 10, 2018

BioDelivery Sciences Reports Strong Second Quarter 2018 Financial Results

BioDelivery Sciences International (NASDAQ:BDSI), a leading specialty pharmaceutical company focused on patients living with chronic pain, today reported financial results...
August 8, 2018

INSYS Therapeutics Reaches Agreement in Principle to Settle Department of Justice Investigation

INSYS Therapeutics (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, announced today that...
August 1, 2018

Aerie Pharmaceuticals and DSM Biomedical Expand Collaboration Agreement

Aerie Pharmaceuticals (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment...
July 12, 2018

Zogenix Announces Positive Top-line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome

Zogenix (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today reported positive...
July 5, 2018

Zynerba Pharmaceuticals Announces Top Line Results from ZYN001 THC-Prodrug Patch Phase 1 Study

Zynerba Pharmaceuticals (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, announced top line results...
July 3, 2018

Eagle Pharmaceuticals Announces New Patent Issued for BENDEKA

Eagle Pharmaceuticals (Nasdaq:EGRX) announced that an additional patent has been issued related to BENDEKA by the United States Patent and Trademark...